These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15164884)

  • 1. km23: a novel TGFbeta signaling target altered in ovarian cancer.
    Ding W; Mulder KM
    Cancer Treat Res; 2004; 119():315-27. PubMed ID: 15164884
    [No Abstract]   [Full Text] [Related]  

  • 2. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
    Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
    Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for the dynein light chain km23-1 in a Smad2-dependent transforming growth factor-beta signaling pathway.
    Jin Q; Ding W; Mulder KM
    J Biol Chem; 2007 Jun; 282(26):19122-32. PubMed ID: 17420258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of km23 for TGFbeta-mediated growth inhibition and induction of fibronectin expression.
    Jin Q; Ding W; Staub CM; Gao G; Tang Q; Mulder KM
    Cell Signal; 2005 Nov; 17(11):1363-72. PubMed ID: 15925487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of a dynein light chain in transforming growth factor β signaling in zebrafish ovarian follicle cells.
    Jin Q; Gao G; Mulder KM
    Mol Cell Endocrinol; 2012 Jan; 348(1):233-40. PubMed ID: 21920407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
    Zhou J; Jain S; Azad AK; Xu X; Yu HC; Xu Z; Godbout R; Fu Y
    Cell Signal; 2016 Aug; 28(8):838-49. PubMed ID: 27075926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ortholog of Drosophila Melted impedes SMAD2 release from TGF-β receptor I to inhibit TGF-β signaling.
    Shathasivam P; Kollara A; Ringuette MJ; Virtanen C; Wrana JL; Brown TJ
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3000-9. PubMed ID: 26039994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFβ Controls Ovarian Cancer Cell Proliferation.
    Alsina-Sanchís E; Figueras A; Lahiguera A; Gil-Martín M; Pardo B; Piulats JM; Martí L; Ponce J; Matias-Guiu X; Vidal A; Villanueva A; Viñals F
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.
    Alsina-Sanchis E; Figueras A; Lahiguera Á; Vidal A; Casanovas O; Graupera M; Villanueva A; Viñals F
    Int J Cancer; 2016 Oct; 139(8):1894-903. PubMed ID: 27299695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of transforming growth factor beta in ovarian surface epithelium biology and ovarian cancer.
    Nilsson EE; Skinner MK
    Reprod Biomed Online; 2002; 5(3):254-8. PubMed ID: 12470522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.
    Bennett D; Alphey L
    Nat Genet; 2002 Aug; 31(4):419-23. PubMed ID: 12134149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signaling: Fleshing out the TGFbeta pathway.
    Padgett RW
    Curr Biol; 1999 Jun; 9(11):R408-11. PubMed ID: 10359694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.
    Gao Y; Fang X; Vincent DF; Threadgill DW; Bartholin L; Li Q
    Reprod Biol Endocrinol; 2017 Dec; 15(1):94. PubMed ID: 29221447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
    Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
    Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and dynamics of the homodimeric dynein light chain km23.
    Ilangovan U; Ding W; Zhong Y; Wilson CL; Groppe JC; Trbovich JT; Zúñiga J; Demeler B; Tang Q; Gao G; Mulder KM; Hinck AP
    J Mol Biol; 2005 Sep; 352(2):338-54. PubMed ID: 16083906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].
    Aoki D; Komiyama S; Susumu N; Nozawa S
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():213-6. PubMed ID: 11235169
    [No Abstract]   [Full Text] [Related]  

  • 17. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.
    Hayashi H; Abdollah S; Qiu Y; Cai J; Xu YY; Grinnell BW; Richardson MA; Topper JN; Gimbrone MA; Wrana JL; Falb D
    Cell; 1997 Jun; 89(7):1165-73. PubMed ID: 9215638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers.
    Campbell IG; Phillips WA; Choong DY
    Clin Cancer Res; 2006 Jun; 12(12):3713-5. PubMed ID: 16778097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.
    Wang T; Li BY; Danielson PD; Shah PC; Rockwell S; Lechleider RJ; Martin J; Manganaro T; Donahoe PK
    Cell; 1996 Aug; 86(3):435-44. PubMed ID: 8756725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD; Nachtigal MW
    Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.